⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANNX News
Annexon, Inc. Common Stock
Annexon Appoints Renowned Retinal Surgeon and Biotechnology Entrepreneur Mark S. Blumenkranz, M.D., M.M.S. to its Board of Directors
globenewswire.com
ANNX
Form 8-K
sec.gov
ANNX
Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week
globenewswire.com
ANNX
Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week
globenewswire.com
ANNX
Form 8-K
sec.gov
ANNX
Annexon Secures Strategic Credit Facility for up to $200 Million from Oxford Finance
globenewswire.com
ANNX
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ANNX
Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026
globenewswire.com
ANNX
New Ownership of AIM Mail Center in Huntington Beach, California Marks New Chapter for Longstanding Business, Led by Former Housing and Urban Development Professional
prnewswire.com
ANNX
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ANNX